Trial intelligence / Profile preview

PRP versus saline injections for chronic tenosynovitis

PACTR202506613254896Completed

Sponsor
Kafrelsheikh University
Start
Jul 2024
Countries
1
01

Overview

Trial of platelet-rich plasma and saline in chronic tenosynovitis (2 arms), sponsored by Kafrelsheikh University. Primary endpoint: Temporal pattern of growth factor release. Started Jul 2024; status: completed.

02

Drugs

platelet-rich plasmasaline
03

Conditions

chronic tenosynovitis

Beyond the preview

Go deeper on PACTR202506613254896.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202506613254896.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call